Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Report and Forecast 2024-2032

Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Outlook

The global enzyme-linked immunosorbent assays (ELISAs) market is expected to grow at a CAGR of 3.0% during the period 2024-2032. The global market is expected to be driven by applications of enzyme-linked immunosorbent assays (ELISAs) in multiple settings, including rapid antibody screening tests for HIV, recognition of other viruses, fungi, bacteria, food allergens, autoimmune diseases, blood typing, presence of the pregnancy hormone hCG, forensic toxicology, laboratory and clinical research, and several other diagnostic settings. ELISAs are sensitive, precise, and inexpensive. These aspects are expected to drive the global market. North America, Europe and Asia are likely to be key markets.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Applications in Various Settings

Enzyme-linked immunosorbent assay (ELISA) is a labelled immunoassay accepted as the gold standard of immunoassays. The immunological test is very sensitive and is employed to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. There are three common variations of enzyme-linked immunosorbent assays (ELISAs) - double antibody sandwich ELISA, indirect ELISA, and competitive ELISA; these have a broad variety of applications, including clinical, forensic and food research. Recognition of cancer biomarkers for early cancer detection is a task continually being researched and developed. Enzyme-linked immunosorbent assay (ELISA) based techniques are available and employed clinically for testing for early phases of cancer (including breast and ovarian cancer).

Enzyme-linked immunosorbent assay (ELISA) is also used to determine concentrations of illegal drugs, like cannabinoids, amphetamines, opiates, cocaine, benzodiazepines, and methadone, in urine samples. Further, the method may be used to monitor levels of pharmaceutical drug concentrations in individuals under treatment, for instance, antidrug antibodies in rheumatoid arthritis and inflammatory bowel disease. Enzyme-linked immunosorbent assay (ELISA) is also usually employed to test for the detection of hormone human chorionic gonadotrophin (hCG) in urine (which is present in higher amounts in pregnant women), thus enabling easy access and home testing capabilities.

Global Market Likely to be Driven by Inexpensive and Precise Solutions Offered by Enzyme-linked Immunosorbent Assays (ELISAs)

Detection of platelet antibodies in serum is employed to recognize individuals suffering from disorders such as idiopathic thrombocytopenic purpura and systemic lupus erythematosus. These tests use alkaline phosphatase (enzyme), labelled with anti-human lgG. While being a less expensive and complicated method for detection of platelet antibodies, enzyme-linked immunosorbent assay (ELISA) is also reported to offer more than other generally employed tests, like the lymphocytotoxicity (LCT) and platelet immunofluorescence test (PIIFT). These aspects are expected to boost the global enzyme-linked immunosorbent assays (ELISAs) market.

In the food industry, enzyme-linked immunosorbent assay (ELISA) is popularly used to determine the presence of allergens for legally required ingredient labelling. The application benefits significantly from the sensitivity of ELISA and is able to detect levels of potential food allergen contaminants at concentrations on lower parts per million (ppm) scale. Further, it may be used to test for oils and other substances such as egg whites or milk, which other methods such as PCR are unable to detect.

Important Applications for Developing Countries Likely to Stimulate Market Growth

The global enzyme-linked immunosorbent assays (ELISAs) market is expected to be stimulated by an important application – detection of viruses – which is especially useful for developing countries with high infection rates. The method can reach the most susceptible groups with on-site testing capabilities and prompt results, enabling opportunistic testing.

Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By test type, the market is segmented into:

• Sandwich ELISA
• Competitive ELISA
• Indirect ELISA
• Multiple and Portable ELISA
• Others

By application, the market is divided into:

• Cancer
• Protein Quantification
• Immunology
• Inflammation
• Infectious Diseases
• Other

By region, the market is classified into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global enzyme-linked immunosorbent assays (ELISAs) market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• BioLegend, Inc.
• Bio-Rad Laboratories, Inc.
• Enzo Life Sciences, Inc.
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report